Institutional Ownership
Dexcom Inc
CUSIP 252131107COMDXCMQ1 2026
Insider Transactions
61
Form 4 lines on record
Reporting Insiders
16
Distinct officers & directors
90d Buys
0
Open-market purchase shares
90d Sells
100.2K
Open-market sale shares
Insider Transactions — Form 4
61 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jul 20, 2026 | Sayer Kevin R | Executive Chair | S · Sell | 26.8K | $76.32 | $2.04M | 329.0K | SEC |
| 2 | Jul 15, 2026 | Brown Michael Jon | EVP Chief Legal Compliance Off | S · Sell | 1.7K | $74.42 | $126.5K | 104.7K | SEC |
| 3 | Jul 6, 2026 | Sayer Kevin R | Executive Chair | S · Sell | 26.8K | $72.00 | $1.93M | 355.7K | SEC |
| 4 | Jun 15, 2026 | Brown Michael Jon | EVP Chief Legal Compliance Off | S · Sell | 1.7K | $75.55 | $128.4K | 106.4K | SEC |
| 5 | Jun 15, 2026 | Foletta Mark G | Director | S · Sell | 3.8K | $74.10 | $281.7K | 53.1K | SEC |
| 6 | Jun 15, 2026 | Foletta Mark G | Director | S · Sell | 199 | $74.82 | $14.9K | 52.9K | SEC |
| 7 | Jun 4, 2026 | Coleman Jon | EVP, Chief Commercial Officer | S · Sell | 4.9K | $74.13 | $364.1K | 95.5K | SEC |
| 8 | Jun 3, 2026 | Coleman Jon | EVP, Chief Commercial Officer | S · Sell | 4.9K | $73.00 | $358.6K | 100.4K | SEC |
| 9 | May 28, 2026 | Altman Steven R | Director | A · Grant | 5.6K | — | — | 5.6K | SEC |
| 10 | May 28, 2026 | Malady Kyle | Director | A · Grant | 5.6K | — | — | 28.2K | SEC |
51 more insider transactions on Premium
See the full Form 4 transaction history for Dexcom Inc.
Unlock all transactions